The analysis looks at the mortality rate for those who continued or started ACEi/ARB treatment and those who discontinued or did not initiate the treatment. Withdrawal of angiotensin-converting enzyme ...

Please provide your email address to receive an email when new articles are posted on . HOUSTON — A personalized alert tool may improve use of angiotensin-converting enzyme inhibitors and angiotensin ...

Importance Women with angina due to suspected ischaemia referred for coronary angiography often have no obstructive coronary ...

Editor's note: Find the latest COVID-19 news and guidance in Medscape's Coronavirus Resource Center. Hospitalized COVID-19 patients with hypertension and on treatment with an renin-angiotensin system ...

The side effects of ACEIs and ARBs may be resulting in less frequent use in a population that could benefit from these medications. A new study found that continuous ACEI/ARB use prior to dialysis ...

A long-running dispute as to the supremacy of angiotensin-converting enzyme (ACE) inhibitors or angiotensin receptor blockers (ARBs) in the treatment of cardiovascular disease should be put to bed ...

High blood pressure and cardiovascular and renal diseases are often treated with a combination of renin-angiotensin-aldosterone system inhibitors. However, as these agents have the potential to cause ...

Patients who had been taking an angiotensin-converting enzyme inhibitor (ACEi) or angiotensin receptor blocker (ARB) for preexisting hypertension had lower in-hospital mortality but stayed longer in ...

Certain high blood pressure medications may help reduce the severity of disease and mortality rates for those infected with the novel coronavirus, according to a new study published in the journal ...

A new study published in the prestigious journal JAMA Cardiology in May 2020 reports that there is no association between the use of ACEIs/ARBs and testing positive for COVID-19. This supports current ...

No significant interactions were seen between ACEi or ARB treatment and age, estimated glomerular filtration rate, albuminuria, or diabetes. HealthDay News — For individuals with advanced chronic ...

Initiation of ACEi or ARB therapy reduces the risk for kidney failure, but does not appear to prolong overall survival in patients with advanced CKD. In patients with advanced chronic kidney disease ...